Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain Reduction with Oral Methotrexate in Knee Osteoarthritis
2013-001689-41Phase 3Unknown
- Sponsor
- University of Leeds
- Start
- Oct 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of methotrexate in knee osteoarthritis (OA) and osteoarthritis (OA) (2 arms), sponsored by University of Leeds. Primary endpoint: Primary: Change in knee pain at 6 months. Status: unknown.
02
Drugs
methotrexate
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on 2013-001689-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001689-41.